Abstract
Purpose
The TNM staging remains the best prognostic descriptor of lung cancer; however, new independent prognostic factors are needed, particularly for early stage disease.
Methods
An evaluation of the pleural lavage cytology (PLC) was performed in 436 consecutive NSCLC patients who underwent surgical resection; clinical, pathological and follow-up data were available for 414 patients.
Results
The PLC was positive in 15 patients (3.6 %). The overall five-year survival was 35.9 % in PLC-positive and 57.8 % in PLC-negative patients (p = 0.004). To compare groups with the same prognostic characteristics, the analysis was restricted to p-stage I patients, but the survival remained worse in the PLC-positive patients (42.9 vs 69.4 %; p = 0.001). Recurrence was also observed more frequently in PLC-positive cases: 69.2 vs 34.5 %, OR 4.28 (95 % CI 1.29–14.18; p = 0.01). Among the PLC-positive patients, no difference between the local (44.4 %) and distant (55.6 %) relapse patterns was found (p = 0.82). The multivariate analysis identified four independent prognostic factors: age (p < 0.001), disease stage (p < 0.001), gender (p = 0.025) and PLC status (p = 0.012).
Conclusions
PLC is an independent prognostic factor for NSCLC. PLC-positive NSCLC patients have a worse overall survival and a higher recurrence rate, even in stage I disease. PLC-positive patients should be considered a high risk category, who should potentially be eligible for adjuvant therapy regardless of their p-stage.
Similar content being viewed by others
References
American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011.
Kondo H, Naruke T, Tsuchiya R, Goya T, Suemasu K, Yamagishi K, et al. Pleural lavage cytology immediate after thoracotomy as a prognostic factor for patients with lung cancer. Jpn J Cancer Res. 1989;80:233–7.
Reif M, Socinski MA, Rivera MP. Evidence based medicine in the treatment of non small cell lung cancer. Clin Chest Med. 2000;21(1):107–20.
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7.
Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9.
AJCC Cancer Staging Manual, 7th ed. New York: Springer, 2010. pp. 253–266.
Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumors, world health organization international histological classification of tumors. Berlin: Springer; 1999.
Buhr J, Berghauser KH, Morr H, Dobroschke J, Ebner HJ. Tumor cells in intraoperative pleural lavage. An indicator for the poor prognosis of bronchogenic carcinoma. Cancer. 1990;65:1801–4.
Okumura M, Ohshima S, Kotake Y, Morino H, Kikui M, Yasumitsu T. Intraoperative pleural lavage cytology in lung cancer patients. Ann Thorac Surg. 1991;51:599–604.
Buhr J, Berghauser KH, Gonner S, Kelm C, Burkhardt EA, Padberg WM. The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. J Thorac Cardiovasc Surg. 1997;113:683–90.
Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Maniwa Y. Role of pleural lavage cytology before resection for primary lung carcinoma. Ann Surg. 1999;229:579–84.
Vinette-Leduc D, Yazdi HM, Valji A, Shamji F, Maziak D. Pre- and postresection thoracic washings in non-small cell carcinoma of the lung: a cytological study of 44 patients without pleural effusion. Diagn Cytopathol. 2000;22(4):218–22.
Okada M, Sakamoto T, Nishio W, Uchino K, Tsuboshima K, Tsubota N. Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. J Thorac Cardiovasc Surg. 2003;126:1911–5.
Lim E, Ali A, Theodorou P, Nicholson AG, Ladas G, Goldstraw P. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:1113–8.
Vicidomini G, Santini M, Fiorello A, Parascandolo V, Calabro B, Pastore V. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer? Ann Thorac Surg. 2005;79:254–7.
Enatsu S, Yoshida J, Yokose T, Nishimura M, Nishiwaki Y, Shirakusa T, et al. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients. Ann Thorac Surg. 2006;81:298–304.
Satoh Y, Hoshi R, Ishikawa Y, Horai T, Okumura S, Nakagawa K. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg. 2007;83:197–202.
Nakagawa T, Okumura N, Kokado Y, Miyoshi K, Matsuoka T, Kameyama K. Clinical relevance of intraoperative pleural lavage cytology in non-small cell lung cancer. Ann Thorac Surg. 2007;83:204–8.
Nakamura T, Suzuki K, Mochizuki T, Ohde Y, Kobayashi H, Nakamura H, et al. Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer. Interact CardioVasc Thorac Surg. 2009;8(3):321–4.
Taniguchi Y, Nakamura H, Miwa K, Adachi Y, Fujioka S, Haruki T, et al. Prognostic significance of pleural lavage cytology after thoracotomy and before closure of the chest in lung cancer. Interact CardioVasc Thorac Surg. 2009;9(1):102–6.
Kawachi R, Nakazato Y, Masui K, Takei H, Koshi-ishi Y, Goya T. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology? Interact CardioVasc Thorac Surg. 2009;9(2):265–8.
Lim E, Clough R, Goldstraw P, Edmonds L, Aokage K, Yoshida J, et al. International pleural lavage cytology collaborators. impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: an international individual patient data meta-analysis. J Thorac Cardiovasc Surg. 2010;139(6):1441–6.
Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H, et al. A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention. J Thorac Cardiovasc Surg. 2002;123(4):695–9.
Muraoka M, Oka T, Akamine S, Tagawa T, Morinaga M, Inoue M, et al. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion. J Surg Oncol. 2006;93(4):323–9.
Acknowledgments
Federico Mazza: surgery, study design, data collection, manuscript writing, final manuscript approval. Enrico Ferrari: data collection, manuscript revision, final manuscript approval. Paola Maineri: surgery, data collection, manuscript revision, final manuscript approval. Beatrice Dozin: statistical analysis, manuscript writing, final manuscript approval. Giovanni Battista Ratto: surgery, study coordinator, manuscript writing, final manuscript approval.
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mazza, F., Ferrari, E., Maineri, P. et al. Pleural lavage cytology predicts recurrence and survival, even in early non-small cell lung cancer. Surg Today 45, 322–328 (2015). https://doi.org/10.1007/s00595-014-0915-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-014-0915-3